Aileen is a co-founder of Psyros and has over 10 years of experience in assay development for medical devices.
In her early career she held management positions in small CROs responsible for protein expression and purification, HLA-B*5701 genotyping and viral load testing.
From 2008 to 2018 in her role as Group Head of Assay Development she led multi-disciplinary teams for VC backed start-up Vivacta Ltd and subsequently the Novartis Near Patient Testing Unit (after acquisition of Vivacta by Novartis in 2012), specializing in detection of target analytes in whole blood for point of care diagnostics.
She received her D. Phil. from the University of Oxford in Biochemistry and Genetics followed by Postdoctoral Research Fellowships at Oxford and the Joslin Diabetes Center, Boston USA (affiliated to Harvard Medical School) researching the genetics of Type 2 diabetes. Aileen has a broad working knowledge of the regulatory requirements for medical devices and brings strong operational and project management skills to the team.